Fierce Pharma

JANUARY 4, 2024

Use of Novo Nordisk and Eli Lilly’s popular diabetes and weight loss drugs come with warnings about a rare intestinal blockage condition called ileus, which can be life threatening. | Use of Novo Nordisk and Eli Lilly’s popular diabetes and weight loss drugs come with warnings about a rare intestinal blockage condition called ileus. Could cautions about more common side effects soon be added to the labels of popular treatments such as Novo’s Ozempic and Lilly’s Mounjaro?

Side effects 344

Side effects FDA Patients 344

MedCity News

JANUARY 4, 2024

Contraline released promising data from the clinical trial it’s conducting to test the efficacy of Adam, its male birth control product. The nonhormonal gel seems to be doing a good job of blocking the flow of sperm to the vas deferens, and no serious adverse events have been reported.

128

128

Fierce Pharma

JANUARY 4, 2024

Despite competitive pressure from a buzzy CRISPR therapy, bluebird bio keeps striding forward with its sickle cell disease gene therapy Lyfgenia. | Despite competitive pressure from a buzzy CRISPR therapy, bluebird bio has signed a second outcomes-based reimbursement agreement for its sickle cell gene therapy Lyfgenia.

Competition 305

Competition 305

MedCity News

JANUARY 4, 2024

Patient Reported Outcome Measures (PROM) scores should be the gold standard for how patients find their doctors, not viewing subjective online reviews of doctors’ ability to satisfy their patients.

Doctors 126

Doctors Patients Physicians 126

Advertisement

What if you could help your sellers stop wasting 72% of their day on non-selling activities and focus on bringing in revenue? Incorporating AI in your enablement workflows can help you cut down on busy work, get projects done faster, and let your team (and you!) focus on making a bigger impact. We put together this guide to show you how to use AI to cut time and costs for projects, including collateral creation, development of training videos, and automating tedious processes.

Sales Management

Fierce Pharma

JANUARY 4, 2024

Even after the heady highs of the COVID-19 era, the contract development and manufacturing organization (CDMO) realm remains one of biopharma's buzziest fields. | Even after the heady highs of the COVID era, the CDMO realm remains one of biopharma's buzziest fields. In 2024, CDMOs can advance their priorities on three fronts, a group of experts said during a recent Evaluate webinar on the state of the industry.

Biopharma 299

Biopharma Manufacturing 299

MedCity News

JANUARY 4, 2024

Mount Sinai is out of network for UnitedHealthcare’s employer-sponsored and individual plans as of January 1 due to a payment dispute. Both parties are likely at fault for getting to this point, one expert declared.

Networking 122

Networking 122

PharmaTimes

JANUARY 4, 2024

Metastatic cancer is estimated to be responsible for 90% of cancer deaths

Patients 122

Patients 122

Fierce Pharma

JANUARY 4, 2024

This year, CVS Health plans to employ the classic "out with the old, in with the new" mantra when it comes to AbbVie’s Humira. | The changes to major commercial formularies will take effect April 1 and favor Humira biosimilar options over the branded drug as part of CVS' efforts to ramp up U.S. biosimilar adoption.

289

289

MedCity News

JANUARY 4, 2024

NewSpring has closed on its fourth healthcare fund, which raised more than $180 million. It has already made six investments, including Healthworks and BetterNight.

Healthcare 119

Healthcare Healthcare 119

Fierce Pharma

JANUARY 4, 2024

As bankers predict a rise in private equity exits this year, one of 2024’s M&A moves could come from the drug manufacturing realm. | Investment giant Bain Capital is weighing a potential sale of its Dutch antibiotics and active pharmaceutical ingredients (API) specialist Centrient Pharmaceuticals, which could be valued as high as €1 billion ($1.09 billion), Bloomberg reported Wednesday, citing people close to the talks.

Manufacturing 278

Manufacturing Sales Pharmaceutical 278

Speaker: Simran Kaur, Founder & CEO at Tattva Health Inc.

The healthcare landscape is being revolutionized by AI and cutting-edge digital technologies, reshaping how patients receive care and interact with providers. In this webinar led by Simran Kaur, we will explore how AI-driven solutions are enhancing patient communication, improving care quality, and empowering preventive and predictive medicine. You'll also learn how AI is streamlining healthcare processes, helping providers offer more efficient, personalized care and enabling faster, data-driven

Patients

MedCity News

JANUARY 4, 2024

Hospitals markedly improved their compliance with price transparency regulations in 2023, according to a new report. It found that more than 90% of hospitals have posted a machine-readable file containing gross charges, negotiated charges and cash prices for the services and items they provide.

118

118

Fierce Pharma

JANUARY 4, 2024

Merck has reportedly settled with insurance companies that contested the pharma giant’s $1.4 billion claim after it was victimized by a crippling cyberattack in 2017. | Merck has settled with insurance companies that contested the pharma giant’s $1.4 billion claim after it was victimized by a crippling cyberattack in 2017, Bloomberg Law reports. With the settlement—terms of which were not disclosed—the insurance companies avoided a ruling that would have provided precedent for other cases involv

Insurance 276

Insurance Pharma 276

PharmaTimes

JANUARY 4, 2024

High amounts of disrupted sleep were found to affect memory and thinking performance

112

112

Fierce Pharma

JANUARY 4, 2024

Article by Richard Pops, CEO of Alkermes | Alkermes, a pioneer in neuroscience therapeutics, is building on its foundation as it emerges as a pure neuroscience company.

Leads 263

Leads Patients 263

Advertisement

Every marketer knows how important it is to prove their efforts drive sales opportunities, but that’s easier said than done. When problems like sales and marketing misalignment, lack of data, and wasted efforts persist, marketers can’t measure, prove, or increase their impact on revenue at a time when demonstrating marketing value is critical. Using analyst and expert data, this guide to marketing impact and content attribution explains: How B2B buyers use content The most common types of conten

Sales

pharmaphorum

JANUARY 4, 2024

Scientists at Roche and Harvard University have discovered a new class of antibiotic that can kill carbapenem-resistant Acinetobacter baumannii (CRAB), a major public health threat

111

111

European Pharmaceutical Review

JANUARY 4, 2024

According to a paper recently published in the Biochemical Engineering Journal , challenges such as strict regulation and lack of industry awareness, limit the adoption of Industrial Internet of Things (IIoT) in bioprocessing and overall bioproduction. As a system that uses various technologies , such as data analytics and artificial intelligence (AI), to transfer data between each other autonomously in an industrial setting, IIoT “enables wide-scope data collection and utilisation, and reduces

Manufacturing 111

Manufacturing Biopharma Engineering Training 111

pharmaphorum

JANUARY 4, 2024

Digital health company Click Therapeutics has won an FDA breakthrough device designation for CT-155, a digital therapeutic (DTx) for the negative symptoms of schizophrenia, like social withdrawal and apathy, that tend not to respond well to antipsychotic drugs.

FDA 111

FDA 111

MedCity News

JANUARY 4, 2024

In aggregate, value based care has yet to produce the consistent, positive results that we seek. But VBC’s slow start is actually a reflection of the difficulty of transitioning away from our entrenched healthcare compensation system.

Healthcare 111

Healthcare Healthcare 111

Advertisement

PharmaVoice

JANUARY 4, 2024

Key strategies for bringing more patients into the clinical trial fold.

Recruitment 105

Recruitment Patients 105

MedCity News

JANUARY 4, 2024

The model will be challenging to implement since the expansive vision and cautious operational model don’t naturally align. But it could see positive reactions from the clinician community which – while seeing the need for change and technological innovation – is deterred by visions of disruption at the operational or at more granular, process levels.

110

110

pharmaphorum

JANUARY 4, 2024

CVS Health will remove AbbVie’s immunology blockbuster Humira from national lists of reimbursable products, and offer biosimilars of the drug instead

105

105

MedCity News

JANUARY 4, 2024

How UPMC Health Plan is taking steps in providing better behavioral health support.

110

110

Advertisement

Quotas need to be hit. Revenue goals need to be met. This reality makes shortening sales onboarding time a top priority. Organizations with a standard onboarding process boost employee retention by 58% and increase productivity by 50%. Unfortunately, many companies struggle with inefficient processes that lead to high turnover and missed revenue opportunities.

Sales

pharmaphorum

JANUARY 4, 2024

Boehringer Ingelheim has signed a collaboration with China’s Ribo to develop treatments for NASH/MASH using siRNA drugs

105

105

PharmExec

JANUARY 4, 2024

Cretostimogene grenadenorepvec (CG0070) is currently being evaluated for the treatment of patients with high-risk Bacillus Calmette-Guérin–unresponsive non–muscle invasive bladder cancer with carcinoma in situ with or without Ta or T1 tumors.

FDA 104

FDA Patients 104

pharmaphorum

JANUARY 4, 2024

Novo Nordisk has reaped the first harvest from its wide-ranging alliance with life sciences investor Flagship Pioneering, buying rights to two programmes from the VC’s portfolio companies Omega Therapeutics and Cellarity.

105

105

Pharmaceutical Commerce

JANUARY 4, 2024

Electronic health record messaging network found to improve communication and lead to better medication adherence.

Electronics 102

Electronics Healthcare Provider Healthcare Healthcare 102

Advertisement

Distribution

pharmaphorum

JANUARY 4, 2024

A digital therapeutic developed by Vicore Pharma and Alex Therapeutics has been shown to reduce anxiety in patients with pulmonary fibrosis in a pivotal trial

Pharma 105

Pharma Patients 105

European Pharmaceutical Review

JANUARY 4, 2024

New research from the US indicates that a prophylactic treatment before immunotherapy can significantly reduce the rate of cytokine release syndrome (CRS) in multiple myeloma patients. Immunotherapy drugs like teclistamab can result in potentially fatal side effects, including CRS and immune cell-associated neurotoxicity syndrome (ICANS). Prophylactic treatment as a preventative measure The new study, published in Blood Cancer Discovery , stated that in the future, this could eliminate the need

Side effects 97

Side effects Food and Drug Administration Patients Medicine 97

pharmaphorum

JANUARY 4, 2024

AbbVie forges $1.

Biopharma 105

Biopharma 105

European Pharmaceutical Review

JANUARY 4, 2024

US researchers have demonstrated the potential of a targeted drug delivery method that uses focused ultrasound in combination with anti-amyloid-beta monoclonal antibody treatment, as a way to accelerate brain amyloid-beta plaque clearance in Alzheimer’s. The paper, published in the New England Journal of Medicine , described that in the first-in-human study, the focused ultrasound system was able to safely and temporarily open the blood-brain barrier to allow the anti-amyloid-beta antibodies inc

Medicine 96

Medicine Patients Leads Pharmaceutical 96

Advertisement

Are your sellers unsure about using AI in their day-to-day workflows? Or are they eager to try but uncertain where to start? They might be asking: Which tasks are best suited for AI? How will using AI affect my relationship with my customers? With so many tools available, which ones are the most useful to me? To help answer these and other common questions about using AI during the sales cycle, we surveyed B2B sellers who were early adopters to get their insight and advice about how to use gen A

Sales